RETINOIC ACID all strengths including 0 recalled over sterility concerns
- Recall date
- February 10, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Synergy Rx recalls RETINOIC ACID all strengths including 0.025%, 0.05% and 0.1% CREAM, RETINOIC ACID 0.025%/CLINDAMYCIN 1.2% GEL, RETINOIC…
- Recall number
- D-0541-2017
- FDA classification
- Class II
- Brand / firm
- Synergy Rx
- Sold / distributed
- Nationwide within the United States
Why it was recalled
Lack of Assurance of Sterility: There are also CGMP Deviations.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
RETINOIC ACID all strengths including 0.025%, 0.05% and 0.1% CREAM, RETINOIC ACID 0.025%/CLINDAMYCIN 1.2% GEL, RETINOIC ACID 0.025%/ HYALURONIC ACID CREAM, RETINOIC ACID 0.05%/HYALURONIC ACID CREAM, RETINOIC ACID 0.1% IN CERAVE CREAM, RETINOIC ACID POWDER 1 GRAM, RETINOIC ACID/HYALURONIC ACID 0.1%/0.1% CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676
Get recall alerts
Free email alert whenever Synergy Rx has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Synergy Rx